Executive Committee

Kalle Känd

CEO

M.D., University of Tartu, Estonia
Degree in Economics, University of Tartu, Estonia

Estonian citizen

Function in Group Management

Chief Executive Officer and Member of Group Management since April 19, 2016

Professional background

  • 2014-16

    Chief Commercial Officer at Acino and a Member of Acino Group Management

  • 2012-14

    Vice President Strategic Planning and Business Support Emerging Markets, Takeda Pharmaceuticals International GmbH, Zurich

  • 2009-11

    Head of Strategic Planning and Alliance Management and Member of the Russian CIS Management Team, Nycomed Russia CIS

  • 2006-08

    International Marketing Director, Nycomed, Denmark

  • 2001-05

    Sales and Marketing Director Baltic States, Nycomed SEFA As

  • 1998-01

    Country Manager Estonia, Berlin-Chemie Menarini Group

  • 1993-98

    Managing Director, TopMed Ltd., Estonia

  • 1991-94

    General Practitioner, Tallinn Pelgulinna Hospital, Tallinn, Estonia, and Helsinki University Hospital, Helsinki, Finland


Geir Myklebust

CFO

Business Economics, Norwegian School of Management BI, Sandvika, Norway

Norwegian citizen

Function in Group Management

CFO Acino Group and Member of Group Management since April, 2014

Professional background

  • 2014-16

    Head of IT and Projects at Acino, Member of Acino Group Management

  • 2011-14

    Head of Finance SSC (Shared Service Centers) Operations, Takeda Pharmaceuticals International GmbH, Zurich

  • 2009-11

    Head of Projects & Systems, Nycomed International Management GmbH, Zurich

  • 2007-08

    Head of Finance Integration, Nycomed International Management GmbH, Zurich

  • 1999-06

    Senior Group Operations Controller, Nycomed Pharma, Norway

  • 1998-99

    SAP Consultant, Finance and Controlling, Nycomed Amersham, Norway

  • 1995-98

    Controller Operations, Nycomed Pharma, Norway


Konstantin Bakaykin

Head of Corporate Business Development

Degree from the Geological Academy of Russian Federation, Moscow, Russia

Russian citizen

Function in Group Management

Head of Corporate Business Development and Member of Group Management since May 16, 2014

Professional background

  • 2012-14

    Head of Business Development for Emerging Markets, Takeda Pharmaceuticals International GmbH, Zurich

  • 2008-12

    Director of Business Development and Marketing Intelligence, Nycomed Russia CIS

  • 2007-08

    Marketing Manager Rx portfolio, Nycomed

  • 2002-07

    Franchise Manager, Bristol-Myers Squibb

  • 1997-02

    Marketing Director, Deputy General Manager, ASTA Medica AG

  • 1997-98

    Head of Consumer Healthcare, ASTA Medica AG

  • 1995-97

    Promotions Manager, SmithKline Beecham pls, Moscow


Sébastien Geneve

Head of Global Medical and Regulatory Affairs

Pharmaceutical doctor from the University of Clermont-Ferrand and Post Graduate Diploma in Pharmacology, Drug Development and Regulation from the Tuft Medical School in Boston, USA.

French citizen

Function in Group Management

Head of Global Medical Affairs, Regulatory Affairs and Pharmacovigilance and Member of Group Management since August, 2016

Professional background

  • 2015-16

    Vice-President Global Regulatory Affairs at Bayer Consumer Care, Basel

  • 2012-15

    Vice-President International Regulatory Affairs at Bayer Consumer Care, Basel

  • 2008-12

    Director Regulatory Affairs Pharmaceutical EMEA at Bausch & Lomb in Zug

  • 2005-08

    Head Regulatory Affairs Gastro-intestinals and other therapeutic areas at Bayer Consumer Care, Basel

  • 2003-04

    Head Regulatory Affairs Gastro-intestinals at Roche Consumer Health near Basel

  • 2000-03

    Global Regulatory Affairs Manager at Roche Consumer Health near Basel

  • 1998-00

    Manager Dossier and Regulatory Issues at Galderma R&D in Princeton, New Jersey, USA

  • 1997-98

    Clinical Project Manager at Galderma Laboratories in Forth Worth, Texas, USA

  • 1996-97

    Scientific Writer at CIRD Galderma in Sophia Antipolis, France


Christina Peusch

Chief Legal & Compliance Officer

German qualified lawyer, University of Passau, Passau, Germany

German citizen

Function in Group Management

Chief Legal & Compliance Officer and Member of Group Management from March 16, 2015

Professional background

  • 2013-15

    Head of Legal EUCAN (Europe/Canada), Emerging Markets and North Asia, Takeda Pharmaceuticals International GmbH, Zurich

  • 2012-13

    Senior Director Corporate Legal Affairs, Takeda Pharmaceuticals International GmbH, Zurich

  • 2010-12

    Senior Director International Legal Affairs, Nycomed Germany Holding GmbH, Konstanz, Germany

  • 2007-09

    Director International Legal Affairs, Nycomed Germany Holding GmbH, Konstanz, Germany

  • 2004-07

    International Legal Affairs Manager, Altana Pharma AG, Konstanz, Germany

  • 1995-04

    Clifford Chance (prev. Pünder, Volhard, Weber & Axster), member of the Commercial Law and Corporate Finance practice areas and (chief) representative of the Beijing office; Frankfurt am Main and Munich, Germany, and Beijing, PRC.


Mario Ricard

Chief Operations Officer

Master of Business Administration and Bachelor of Science – Mechanical Engineering from the University of Sherbrooke in Canada.

Canadian citizen

Function in Group Management

Chief Operations Officer and Member of Group Management since February 15, 2017

Professional background

  • 2015-17

    Vice President – Plasma Manufacturing Europe at Baxalta/Shire, Zurich

  • 2014-15

    Vice President – Operations Strategy at Baxter, Zurich

  • 2012-14

    Vice President – Technical Services and BioSurgery Manufacturing at Baxter, Belgium and Switzerland

  • 2010-12

    Operations Director at Baxter, Belgium

  • 2003-10

    Plant Manager at Baxter, Belgium

  • 1999-03

    Plant Manager at Baxter, Canada

  • 1992-99

    Various roles in Production, Purchasing and Planning at Baxter, Canada


Kieran Scott

Chief Human Resources Officer

Masters Degree in Strategic Human Resources Management, Coventry Business School and Post Graduate Diploma from Croydon Business School, UK

British citizen

Function in Group Management

Chief Human Resources Officer and Member of Group Management since May, 2016

Professional background

  • 2015-16

    Human Resources Director Middle East and Africa, Acino, Dubai

  • 2013-13

    Global Head of HR at KCA Deutag, Dubai

  • 2010-13

    Regional HR Director at Al Habtoor Leighton Group, Dubai

  • 2009-10

    Group Human Resources Director at Bank Albilad, Riyadh, Saudi Arabia

  • 2005-08

    HR Director Europe and Middle East at Aggreko, London and Paris

  • 2002-05

    HR Director at Virgin Media Communications, London

  • 1998-02

    European HR Director at AT&T Communications, Birmingham

  • 1994-97

    HR Manager at Lloyds Register Quality Assurance, London

  • 1991-94

    Personnel & Training Manager at South Thames Training & Enterprise Council, London

  • 1987-91

    Personnel Officer at Pencol Oil and Gas Engineering, London


Ulrike Seminati

Head of Corporate Communications

Masters Degree in Marketing Management, EM Business School of Robert Schuman University in Strasbourg, France

German citizen

Function in Group Management

Head of Corporate Communications and Member of Group Management since July 1, 2015

Professional background

  • 2013-15

    Head of Communications Switzerland, Syngenta Crop Protection AG, Basel, Switzerland

  • 2011-13

    Global Internal Communications Manager, Syngenta Crop Protection AG, Basel, Switzerland

  • 2009-11

    Communications Services Manager, Syngenta International AG, Basel, Switzerland

  • 2006-07

    Online Marketing Manager, Arte TV, Strasbourg, France

  • 2000-06

    Head of Communication Center smart, Daimler Group, Hambach, France


Board of Directors

Håkan Björklund

Ph.D. in Neuroscience, Karolinska Institutet, Sweden

Swedish citizen

Board membership and executive mandates within the Acino Group

  • Chairman of the Board of Acino International AG since December 17, 2013
  • Current term of office on the Board expires in 2017

Professional background

Håkan Björklund joined Avista Capital Partners in October 2011. Mr. Björklund is the former Chief Executive Officer of Nycomed, which was sold to Takeda Pharmaceuticals in September 2011. Under Mr. Björklund’s leadership, Nycomed grew from a predominantly Scandinavian business into a global pharmaceutical company with leading market positions in Europe, Russia/CIS, Brazil and Latin America. Prior to Nycomed, Mr. Björklund was Regional Director at Astra (now AstraZeneca) and, earlier, President of Astra Draco. He is Chairman of the Board of Directors at Lundbeck A/S, a member of the Board of Directors of Alere Inc., Coloplast A/S and Atos Medical AB. He was also a director at Danisco A/S until its recent acquisition by Dupont.


Toni Weitzberg

B.Sc. in Economics and Business Administration, University of Uppsala, Sweden

MBA, University of Wisconsin, USA

Citizen of Sweden

Board membership and executive mandates within the Acino Group

  • Vice-Chairman of the Board of Acino International AG since December 17, 2013
  • Current term of office expires in 2017

Professional background

Toni Weitzberg joined NC Advisory AB, advisor to the Nordic Capital funds, in 2000. Prior to joining, Mr. Weitzberg held various executive positions within the Pharmacia Group, most recently as Senior Vice President and Head of Pharmacia Europe. He currently serves as a board member of Convatec and Handicare. Mr. Weitzberg is the former Chairman of Dynal, Biovitrum, Atos, Nycomed, as well as a former board member of Fougera Pharmaceuticals, Unomedical and Permobil.


Jonas Agnblad

M.Sc. in Finance and International Business, Stockholm School of Economics, Sweden

Swedish citizen

Board membership and executive mandates within the Acino Group

  • Member of the Board of Acino International AG since
    December 17, 2013
  • Current term of office expires in 2017

Professional background

Jonas Agnblad joined NC Advisory AB, advisor to the Nordic Capital funds, in 2000. From 1999 to 2000, Mr. Agnblad worked in the corporate finance department at Warburg Dillon Read in London. He was previously a board member of Nycomed and Fougera Pharmaceuticals and is currently a board member of The Binding Site. Mr. Agnblad is based in Stockholm and focuses on the healthcare sector.


Tom Dean

BA, University of Virginia, USA

MBA, Harvard Business School, USA

Citizen of the Untied States of America

Board membership and executive mandates within the Acino Group

  • Member of the Board of Acino International AG since
    December 17, 2013
  • Current term of office expires in 2017

Professional background

Tom Dean is the Co-Managing Partner and Co-CEO of Avista Capital Partners. Prior to co-founding Avista Capital Partners in 2005, Mr. Dean led DLJ Merchant Banking Partners (“DLJMB”), serving as Co-Managing Partner of DLJMB since 1995 and Chairman of the Investment Committees of DLJMB I, DLJMB II, DLJMB III and DLJ Growth Capital Partners through December 2007. Mr. Dean currently serves on the boards of ConvaTec, Sidewinder Drilling, Zest Anchors, and VWR International. Mr. Dean formerly served as the Chairman of the board of Nycomed, Arcade, DeCrane Aircraft, Mueller and Von Hoffmann. He also formerly served on the boards of American Ref-Fuel, Argyle Television, BioPartners, Charles River Labs, Evergreen Media, Merrill, Safilo, Visant and IWCO Direct Holdings, among others.


Johan Ek

MSc in Economics, Hanken School of Economics in Helsinki, Finland

Citizen of Sweden

Board membership and executive mandates within the Acino Group

  • Member of the Board of Acino International AG since February 22, 2017
  • Current term of office on the Board expires in 2018

Professional background

Johan Ek, has worked as an Industrial Advisor to the Nordic Capital Funds since July 2012. Johan is currently Chairman of the Board of Sunrise Medical and Saferoad and vice Chairman of the Board of Handicare. He was previously Chairman on the board of CPS. Johan also works as an investor through his own business. Johan started his career at McKinsey & Company as a management consultant. He then joined LGP Allgon AB and served in various positions including President, and later became President of Business Unit Europe at Powerwave Technologies Inc. between 2005-2012, Johan worked as President and CEO of the Relacom Group.


Kunal Pandit

M.A. and B.A., Cambridge University, USA
MBA, Wharton School at the University of Pennsylvania, USA

Citizen of the United Kingdom

Board membership and executive mandates within the Acino Group

  • Member of the Board of Acino International AG since December 17, 2013
  • Current term of office expires in 2017

Professional background

Kunal Pandit joined Avista Capital Partners in 2010. Mr. Pandit was previously at DLJ Merchant Banking Partners (“DLJMB”) in London. Prior to DLJMB, Mr. Pandit was a member of the leveraged finance group and the investment banking department at Lehman Brothers in London. He currently serves as a director of Guala Closures.


Thomas Vetander

M.Sc. in Engineering Physics, Royal Institute of Technology of Stockholm, Sweden
B.Sc. in Business Administration and Economics, Stockholm University School of Business, Sweden

Swedish citizen

Board membership and executive mandates within the Acino Group

  • Member of the Board of Acino International AG since December 17, 2013
  • Current term of office expires in 2017

Professional background

Thomas Vetander joined NC Advisory AB, advisor to the Nordic Capital funds, in 2006. From 2004 to 2006, Mr. Vetander worked as a Management Consultant at McKinsey & Company in Stockholm. Mr. Vetander serves on the board of Handicare and as a deputy board member of Convatec.